The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

Martini, 1995, Mediastinal lymph node dissection for lung cancer. The Memorial experience, Chest Surg Clin N Am, 5, 189

Ferguson, 1986, The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer, J Thorac Cardiovasc Surg, 91, 344, 10.1016/S0022-5223(19)36049-0

Maggi, 1990, Resection and radical lymphadenectomy for lung cancer: prognostic significane of lymphatic metastases, Int Surg, 75, 17

Martini, 1992, Survival after resection of stage II non-small cell lung cancer, Ann Thorac Surg, 54, 460, 10.1016/0003-4975(92)90435-7

Yano, 1994, Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes, J Thorac Cardiovasc Surg, 107, 1398, 10.1016/S0022-5223(94)70413-9

van Velzen, 1996, Type of lymph node involvement influences survival rates of T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases, Chest, 110, 1469, 10.1378/chest.110.6.1469

van Velzen, 1997, Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma, Ann Thorac Surg, 63, 1436, 10.1016/S0003-4975(97)00089-1

van Velzen, 1999, Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma, Ann Thorac Surg, 67, 903, 10.1016/S0003-4975(99)00123-X

Sawyer, 1999, Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma, Ann Thorac Surg, 68, 1171, 10.1016/S0003-4975(99)00678-5

Riquet, 1999, Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung, Ann Thorac Surg, 67, 1572, 10.1016/S0003-4975(99)00276-3

Yoshino, 1999, Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases, Chest, 116, 144, 10.1378/chest.116.1.144

Asamura, 2000, Where is the boundary between N1 and N2 stations in lung cancer?, Ann Thorac Surg, 70, 1839, 10.1016/S0003-4975(00)01817-8

Marra, 2003, Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis, J Thorac Cardiovasc Surg, 125, 543, 10.1067/mtc.2003.322

Naruke, 1978, Lymph node mapping and curability at various levels of metastasis in resected lung cancer, J Thorac Cardiovasc Surg, 76, 833, 10.1016/S0022-5223(19)39559-5

Martini, 1983, Prognostic significance of N1 disease in carcinoma of the lung, J Thorac Cardiovasc Surg, 86, 646, 10.1016/S0022-5223(19)39079-8

Miller, 1994, Results of surgical resection in patients with N2 non-small cell lung cancer, Ann Thorac Surg, 57, 1095, 10.1016/0003-4975(94)91335-8

Goldstraw, 1994, Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease), J Thorac Cardiovasc Surg, 107, 19, 10.1016/S0022-5223(94)70447-3

Riquet, 1995, Factors determining survival in resected N2 lung cancer, Eur J Cardiothorac Surg, 9, 300, 10.1016/S1010-7940(05)80186-1

Okada, 1999, Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival?, J Thorac Cardiovasc Surg, 118, 270, 10.1016/S0022-5223(99)70217-5

Asamura, 1999, Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis, J Thorac Cardiovasc Surg, 117, 1102, 10.1016/S0022-5223(99)70246-1

Sagawa, 1999, Five-year survivors with resected pN2 nonsmall cell lung carcinoma, Cancer, 85, 864, 10.1002/(SICI)1097-0142(19990215)85:4<864::AID-CNCR13>3.0.CO;2-Q

Andre, 2000, Survival of patients with resected N2 non-small cell lung cancer: evidence for a subclassification and implications, J Clin Oncol, 18, 2981, 10.1200/JCO.2000.18.16.2981

Naruke, 2001, Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience, Ann Thorac Surg, 71, 1759, 10.1016/S0003-4975(00)02609-6

Ichinose, 2001, Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station, J Thorac Cardiovasc Surg, 122, 803, 10.1067/mtc.2001.116473

Ueda, 2003, Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer, Jpn J Thorac Cardiovasc Surg, 51, 297, 10.1007/BF02719381

Inoue, 2004, Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe, J Thorac Cardiovasc Surg, 127, 1100, 10.1016/j.jtcvs.2003.09.012

Keller, 2004, Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease, J Thorac Cardiovasc Surg, 128, 130, 10.1016/j.jtcvs.2003.11.061

Goldstraw, 2006, The International Association for the Study of Lung Cancer international staging project on lung cancer, J Thorac Oncol, 1, 281, 10.1016/S1556-0864(15)31581-1

The Japan Lung Cancer Society, 2000

Mountain, 1997, Regional lymph node classification for lung cancer staging, Chest, 111, 1718, 10.1378/chest.111.6.1718

Jett, 1997, Pretreatment evaluation of non-small cell lung cancer, Am J Respir Crit Care Med, 156, 320, 10.1164/ajrccm.156.1.ats156.1

Tisi, 1983, Clinical staging of primary lung cancer, Am Rev Respir Dis, 127, 659, 10.1164/arrd.1983.127.5.659

Cahan, 1951, Radical pneumonectomy, J Thorac Cardiovasc Surg, 22, 449

Mountain, 1997, Revisions in the International System for Staging Lung Cancer, Chest, 111, 1710, 10.1378/chest.111.6.1710

Vansteenkiste, 1997, Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases, Ann Thorac Surg, 63, 1441, 10.1016/S0003-4975(97)00314-7

Misthos, 2004, Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer, Eur J Cardiothorac Surg, 25, 502, 10.1016/j.ejcts.2004.01.025

Prenzel, 2003, Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer, J Surg Oncol, 82, 256, 10.1002/jso.10219

Libshitz, 1986, Patterns of mediastinal metastases in bronchogenic carcinoma, Chest, 90, 229, 10.1378/chest.90.2.229

Yoshino, 1996, Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer, Ann Thorac Surg, 62, 1021, 10.1016/0003-4975(96)00470-5

Tsubota, 1996, Skip metastasis and hidden N2 disease in lung cancer: how successful is mediastinal dissection?, Surg Today, 26, 169, 10.1007/BF00311501

Takizawa, 1997, Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small cell lung cancer, J Thorac Cardiovasc Surg, 113, 248, 10.1016/S0022-5223(97)70320-9

Okada, 1998, Proposal for reasonable mediastinal lymphadenectomy in brocnhogenic carcinomas: role of subcarinal nodes in selective dissection, J Thorac Cardiovasc Surg, 116, 949, 10.1016/S0022-5223(98)70045-5

Ohta, 2006, Results of initial operations in non-small cell lung cancer patients with single-level N2 disease, Ann Thorac Surg, 81, 427, 10.1016/j.athoracsur.2005.08.018